Breaking News Instant updates and real-time market news.

MGP Ingredients management to meet with SunTrust

Meeting to be held on the West Coast on September 13 hosted by SunTrust.

MGPIMGP Ingredients

$58.36

-0.59 (-1.00%)

05/05/17

SIDC

05/05/17DOWNGRADESIDCNeutral

MGP Ingredients downgraded to Neutral from Buy at Sidoti

Sidoti downgraded MGP Ingredients to Neutral citing valuation and mainly the "massive" buildup across the industry in aging whiskey inventory.

05/05/17

CHLM

05/05/17NO CHANGETarget $70CHLMBuy

MGP Ingredients price target raised to $70 from $60 at Craig-Hallum

Craig-Hallum analyst Alex Fuhrman raised his price target for MGP Ingredients to $70 from $60 as total Q1 revenue results exceeded his estimate as food grade alcohol revenue was ahead of expectations, fueled by growth in beverage alcohol. The analyst reiterates a Buy rating on the shares.

Craig-Hallum analyst Alex Fuhrman believes MGP Ingredients continues to execute on its long and short-term objectives after attending its Analyst Day. Fuhrman remains bullish on the stock ahead of a "significant acceleration" in earnings growth beginning in 2019. He reiterates a Buy rating and $60 price target on the shares.

03/09/17

CHLM

03/09/17NO CHANGETarget $60CHLMBuy

MGP Ingredients price target raised to $60 from $50 at Craig-Hallum

Craig-Hallum analyst Alex Fuhrman raised his price target for MGP Ingredients to $60 from $50 following a "solid Q4 beat" and "strong" initial guidance. The analyst reiterates a Buy rating on the shares.

UP AFTER EARNINGS: Cintas (CTAS), up 2.9%... Micron (MU), up 2.8%. ALSO HIGHER: Editas Medicine (EDIT), up 3.1% after it received the EMA's orphan medicinal product designation for EDIT-101... Twitter (TWTR), up 1.8% after it said it will start testing longer, 280-character tweets with a small group. DOWN AFTER EARNINGS: Nike (NKE), down 3.2%. ALSO LOWER: Kornit Digital (KRNT), down 12.2% after it cut its third quarter revenue guidance... Westlake Chemical Partners (WLKP), down 8.3% after it filed to sell 4.5M units for limited partners... Intra-Cellular (ITCI), down 7.2% after it filed to sell $150M in common stock... Ascendis Pharma (ASND), down 4.3% after it announced an offering of $125M of ADSs.